GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
Z20.2
Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
ICD10CM code
Medical Policies and Guidelines for Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
Related policies from health plans
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Preventive Care Services - (A004)
Similar Codes
ICD10CM codes
Z20.2
- Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
Z11.3
- Encounter for screening for infections with a predominantly sexual mode of transmission
Z22.4
- Carrier of infections with a predominantly sexual mode of transmission
Z20.8
- Contact with and (suspected) exposure to other communicable diseases
Z20.9
- Contact with and (suspected) exposure to unspecified communicable disease
Z20.89
- Contact with and (suspected) exposure to other communicable diseases
Z20.6
- Contact with and (suspected) exposure to human immunodeficiency virus [HIV]
Z20.828
- Contact with and (suspected) exposure to other viral communicable diseases
Z20.82
- Contact with and (suspected) exposure to other viral communicable diseases
Z20
- Contact with and (suspected) exposure to communicable diseases
HCPCS codes
S8301
- Infection control supplies, not otherwise specified
G9228
- Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for
G0445
- High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, indivi
H2029
- Sexual offender treatment service, per diem
G9416
- Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the
G0432
- Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, scree
U0004
- 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (i
J3485
- Injection, zidovudine, 10 mg
G8959
- Clinician treating major depressive disorder communicates to clinician treating comorbid condition
G9223
- Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below
CPT4 codes
4293F
- Patient screened for high-risk sexual behavior (HIV)
87110
- Culture, chlamydia, any source
3511F
- Chlamydia and gonorrhea screenings documented as performed (HIV)
00920
- Anesthesia for procedures on male genitalia (including open urethral procedures); not otherwise spec
99170
- Anogenital examination, magnified, in childhood for suspected trauma, including image recording when
87510
- Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, direct probe techniq
12041
- Repair, intermediate, wounds of neck, hands, feet and/or external genitalia; 2.5 cm or less
87810
- Infectious agent antigen detection by immunoassay with direct optical observation; Chlamydia trachom
12047
- Repair, intermediate, wounds of neck, hands, feet and/or external genitalia; over 30.0 cm
87808
- Infectious agent antigen detection by immunoassay with direct optical observation; Trichomonas vagin